circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer

Tamoxifen is the most commonly used endocrine therapy for patients with hormone receptor (HR)-positive breast cancer. Despite its initial therapeutic efficacy, many patients eventually develop drug resistance, which remains a serious clinical challenge. To investigate roles of circular RNAs (circRNA...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mol Ther
Glavni autori: Sang, Yuting, Chen, Bing, Song, Xiaojin, Li, Yaming, Liang, Yiran, Han, Dianwen, Zhang, Ning, Zhang, Hanwen, Liu, Ying, Chen, Tong, Li, Chen, Wang, Lijuan, Zhao, Wenjing, Yang, Qifeng
Format: Artigo
Jezik:Inglês
Izdano: American Society of Gene & Cell Therapy 2019
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6731174/
https://ncbi.nlm.nih.gov/pubmed/31153828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2019.05.011
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items